Production (Stage)
D
MEI Pharma, Inc. MEIP
$6.74 $0.142.12% NASDAQ
Recommendation
Prev Close
$6.74
Volume
590,332
Avg Vol (90D)
644,643
Market Cap
$44.91M
Dividend & Yield
--
52-Week Range
$1.46 - $9.00
P/E (TTM)
--
EPS (TTM)
-$4.75
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
MEI Pharma's Strategic Shift with Litecoin Treasury
7/22/2025 - TipRanks Financial Blog
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury ...
7/22/2025 - GuruFocus
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury ...
7/22/2025 - GuruFocus
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange
7/22/2025 - Business Wire
MEI Pharma Trades Cash For LTC
7/22/2025 - Stocktwits News Feed
Why Litecoin Soared Over the Weekend
7/21/2025 - Fool.com Headlines
MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange
7/20/2025 - Insider Monkey
MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange
7/20/2025 - Yahoo! Finance: News
Why Is MEI Pharma Stock Soaring On Friday?
7/18/2025 - Benzinga
GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee
7/18/2025 - Yahoo! Finance: News
MEI Pharma Announces $100M Placement To Initiate Litecoin Treasury Strategy: Retail Cheers Charlie Lee's Addition To Company Board
7/18/2025 - Stocktwits News Feed
Litecoin Price Forecast: LTC reclaims $100 as NASDAQ-listed MEI Pharma unveils $100 million treasury
7/18/2025 - FXStreet News
First Strategy, Now MEI Pharma: Litecoin Joins Bitcoin As Treasury Asset
7/18/2025 - Benzinga
MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, ...
7/18/2025 - GuruFocus
MEI Pharma (MEIP) Secures $100M Through Private Equity Investment MEIP Stock News
7/18/2025 - GuruFocus
Why Is MEI Pharma Stock (MEIP) Up 85% Today?
7/18/2025 - TipRanks Financial Blog
GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee
7/18/2025 - Invezz News
GSR leads $100M private placement into MEI Pharma to launch Litecoin treasury
7/18/2025 - Invezz News
MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, ...
7/18/2025 - GuruFocus
MEI Pharma soars after $100M litecoin treasury move, first public LTC holder on U.S. exchange
7/18/2025 - Seeking Alpha - Healthcare
MEI Pharma to sell 29.24M shares at $3.42 in private placement
7/18/2025 - The Fly
MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange
7/18/2025 - Business Wire
Litecoin surges as Luxxfolio hikes LTC stake, Mei Pharma reveals $100M treasury
7/18/2025 - Invezz News
MEI Pharma (NASDAQ:MEIP) Posts Earnings Results
5/14/2025 - Ticker Report
MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position MEIP Stock News
5/13/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$0.00
EBITDA (TTM)
-$16.65M
EBIT (TTM)
-$17.14M
Net Income (TTM)
-$31.66M
Balance Sheet
Total Assets (Q)
$20.78M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$1.24M
Book Value Per Share (Q)
$2.93
Cash Flow
Cash from Operations (TTM)
-$36.38M
Cash from Investing (TTM)
$54.69M
Cash from Financing (TTM)
-$208.00K
Net Change in Cash (TTM)
$18.10M
Filings
Filing Date
Tuesday, May 13, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Sep 15 and 19 (est)
Price History
Loading...
Beta
0.06
7-Day Total Return
49.78%
30-Day Total Return
198.23%
60-Day Total Return
230.39%
90-Day Total Return
182.01%
Year to Date Total Return
164.31%
1-Year Total Return
89.33%
2-Year Total Return
14.47%
3-Year Total Return
-11.73%
5-Year Total Return
-85.44%
52-week Low
Apr 16, 2025 - $1.46
52-week High
Jul 18, 2025 - $9.00
Valuation
Market Cap
$44.91M - Nano Cap
Enterprise Value
$24.44M
Price/Sales (TTM)
--
Price/Book (Q)
2.30
Dividends and Shares
Shares Outstanding
6.66
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
meipharma.com
Phone Number
858 369 7100
Address
9920 Pacific Heights Blvd.
San Diego, CA 92121
Country
United States
Year Founded
2000
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor... more
NASDAQ 07/25/2025 4:00PM Eastern Quotes delayed